insights_auto
Why is ARGX down 13,15%?
Dive Deeperchevron_right
ARGX:NASDAQ
argenx SE - ADR
806,36 USD
arrow_downward
-13,15%(-122,08) 1D
8-окт., 12:19:10 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
831,23 USD
High
832,24 USD
Low
787,73 USD
Mkt. cap
51,05 млд
Avg. vol.
263,56 миң
Volume
1,61 млн
P/E ratio
30,64
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 миң
Open
831,23 USD
High
832,24 USD
Low
787,73 USD
Mkt. cap
51,05 млд
Avg. vol.
263,56 миң
Volume
1,61 млн
P/E ratio
30,64
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
Benzinga
·
16 мүнөт мурун
Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings
GuruFocus
·
22 мүнөт мурун
argenx (ARGX) Reports Mixed Clinical Trial Results, Shares Drop 14%
News Corp
·
36 мүнөт мурун
Argenx Stock Sinks as Scrapped Vyvgart Trial Erases $3.5 Billion Opportunity
Barron's
·
36 мүнөт мурун
Argenx Stock Sinks as Scrapped Vyvgart Trial Erases $3.5 Billion Opportunity
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR